Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 384; no. 14; pp. 1289 - 1300
Main Authors:	Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E., Kopyltsov, Evgeny, Méndez-Vidal, María J., Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R., Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C., Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E., Smith, Alan D., Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F., Xing, Dongyuan, Choueiri, Toni K.
Format:	Journal Article
Language:	English
Published:	08-04-2021
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMoa2035716